Wilder B J, Willmore L J, Bruni J, Villarreal H J
Neurology. 1978 Sep;28(9 Pt 1):892-6. doi: 10.1212/wnl.28.9.892.
The interaction of valproic acid and other antiepileptic drugs was studied in 25 patients for 5 to 9 months. Clinical evaluations, seizure records, and antiepileptic drug levels were followed regularly. Eleven of the 13 patients required a reduced phenobarbital dose when concurrently treated with valproic acid. This reduction was prompted by sedation. An average dose reduction of 46 percent resulted in an average serum phenobarbital decrease of 15 percent. Ten of 15 patients had decreased phenytoin concentrations during concurrent administration with valproic acid. No definitive conclusion was reached about other antiepileptic drugs. Decreased phenobarbital excretion because of urine acidification and displacement of phenytoin from protein binding sites may account for the observations. Careful monitoring of anticonvulsant levels is required in anticipation of the documented interactions.
对25例患者进行了5至9个月的丙戊酸与其他抗癫痫药物相互作用的研究。定期进行临床评估、癫痫发作记录及抗癫痫药物血药浓度监测。13例患者中有11例在同时服用丙戊酸时需要减少苯巴比妥剂量。这种减少是由镇静作用引起的。平均剂量减少46%导致血清苯巴比妥平均下降15%。15例患者中有10例在同时服用丙戊酸期间苯妥英浓度降低。关于其他抗癫痫药物未得出明确结论。尿酸化导致苯巴比妥排泄减少以及苯妥英从蛋白结合位点被置换可能解释了这些观察结果。鉴于已记录的相互作用,需要仔细监测抗惊厥药物的血药浓度。